Evidence map›Paper›PMID 26176264›Full record

ArticleAutophagy2015

Disruption of the ribosomal P complex leads to stress-induced autophagy.

Ana Artero-Castro, Mileidys Perez-Alea, Andrea Feliciano, Jose A Leal, Mónica Genestar, Josep Castellvi, Vicente Peg, Santiago Ramón Y Cajal, Matilde E L Lleonart

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The multifaceted roles of ribosomal P complex in cancer.World journal of surgical oncology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Research Progress of Ribosomal Proteins in Reproductive Development.International journal of molecular sciences · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Ana Artero-Castroa Oncology and Pathology Group ; Pathology Department; Institut de Recerca Hospital Vall d'Hebron ; Barcelona , Spain.
Mileidys Perez-Aleaa Oncology and Pathology Group ; Pathology Department; Institut de Recerca Hospital Vall d'Hebron ; Barcelona , Spain.
Andrea Felicianoa Oncology and Pathology Group ; Pathology Department; Institut de Recerca Hospital Vall d'Hebron ; Barcelona , Spain.
Jose A Leala Oncology and Pathology Group ; Pathology Department; Institut de Recerca Hospital Vall d'Hebron ; Barcelona , Spain.
Mónica Genestara Oncology and Pathology Group ; Pathology Department; Institut de Recerca Hospital Vall d'Hebron ; Barcelona , Spain.
Josep Castellvia Oncology and Pathology Group ; Pathology Department; Institut de Recerca Hospital Vall d'Hebron ; Barcelona , Spain.
Vicente Pega Oncology and Pathology Group ; Pathology Department; Institut de Recerca Hospital Vall d'Hebron ; Barcelona , Spain.
Santiago Ramón Y Cajala Oncology and Pathology Group ; Pathology Department; Institut de Recerca Hospital Vall d'Hebron ; Barcelona , Spain.
Matilde E L Lleonarta Oncology and Pathology Group ; Pathology Department; Institut de Recerca Hospital Vall d'Hebron ; Barcelona , Spain.
Pediatric Oncology Group · CAVall d'Hebron Institut de Recerca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human ribosomal P complex, which consists of the acidic ribosomal P proteins RPLP0, RPLP1, and RPLP2 (RPLP proteins), recruits translational factors, facilitating protein synthesis. Recently, we showed that overexpression of RPLP1 immortalizes primary cells and contributes to transformation. Moreover, RPLP proteins are overexpressed in human cancer, with the highest incidence in breast carcinomas. It is thought that disruption of the P complex would directly affect protein synthesis, causing cell growth arrest and eventually apoptosis. Here, we report a distinct mechanism by which cancer cells undergo cell cycle arrest and induced autophagy when RPLP proteins are downregulated. We found that absence of RPLP0, RPLP1, or RPLP2 resulted in reactive oxygen species (ROS) accumulation and MAPK1/ERK2 signaling pathway activation. Moreover, ROS generation led to endoplasmic reticulum (ER) stress that involved the EIF2AK3/PERK-EIF2S1/eIF2α-EIF2S2-EIF2S3-ATF4/ATF-4- and ATF6/ATF-6-dependent arms of the unfolded protein response (UPR). RPLP protein-deficient cells treated with autophagy inhibitors experienced apoptotic cell death as an alternative to autophagy. Strikingly, antioxidant treatment prevented UPR activation and autophagy while restoring the proliferative capacity of these cells. Our results indicate that ROS are a critical signal generated by disruption of the P complex that causes a cellular response that follows a sequential order: first ROS, then ER stress/UPR activation, and finally autophagy. Importantly, inhibition of the first step alone is able to restore the proliferative capacity of the cells, preventing UPR activation and autophagy. Overall, our results support a role for autophagy as a survival mechanism in response to stress due to RPLP protein deficiency.

Indexed as

AutophagyEndoplasmic Reticulum StressAcetylcysteineApoptosisBreast NeoplasmsCell CycleCell Line, TumorCell ProliferationDown-RegulationFemaleHEK293 CellsHumansMitochondriaModels, BiologicalMultiprotein ComplexesOxidation-ReductionAcetylcysteineMultiprotein ComplexesReactive Oxygen SpeciesRibosomal ProteinsRNA, Small InterferingautophagycancerER stressROSRPLP0RPLP1RPLP2RPLP proteinsUPR

Identifiers

PMID26176264
PMCPMC4590587
OpenAlexW1706227909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.